secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001420720-24-000002
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio files updated corporate presentation; no financial details in filing
-------------------------------------------------------------------------

- Company furnished a new investor presentation dated January 2024 as Exhibit 99.1.
- Presentation title emphasizes precision antibody therapeutics and machine learning.
- No specific financial metrics, guidance, or operational updates disclosed in the filing text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072024000002/0001420720-24-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072024000002/ibio-20240108x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-24-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer